Chrysalis Intelligence · Sponsors · Microgenics Corporation

Microgenics Corporation

Fremont, CA, US · 6 510(k) clearances · 2 recalls

Total clearances
6
2021-09-24 → 2024-12-11
Last 12 months
0
Product codes
5
Most recent
2024-12-11
Trend

Clearance cadence by quarter

Portfolio

Product codes worked

Code Device name Class Specialty Clearances Most recent
LFH U.V. Spectrometry, Tricyclic Antidepressant Drugs Class II Clinical Toxicology 2 2023-11-17
JXM 1 2024-12-11
DKZ 1 2024-10-30
DJG Enzyme Immunoassay, Opiates Class II Clinical Toxicology 1 2023-09-27
DIO Enzyme Immunoassay, Cocaine And Cocaine Metabolites Class II Clinical Toxicology 1 2021-09-24
Safety

Recalls (2)

Class I (serious)
0
Risk of injury / death
Total recalls
2
Currently ongoing
2
Most recent
2025-10-01
DateSeverityStatusRecall # ProductCodeReason
2025-10-01 Class II Ongoing Z-0415-2026 Thermo scientific MAS Omni CARDIO, Liquid Assayed Integrated Cardiac Control, Model/Catalog Number: OCRD-L, OCRD-101, OC… The firm received complaints from customers reporting vial-to-vial variability when using the control with high sensitivity Troponin I assays. This defect may l…
2022-01-20 Class II Ongoing Z-1284-2022 QMS Tacrolimus Immunoassay REF 10015573 CALIBRATOR SET QMS TACROLIMUS CAL A 10015566-3 QMS TACROLIMUS CAL B 10015567… Due to QMS Tacrolimus Calibrator recovering between 82 to 94% of their target values, resulting in over-quantitation in tacrolimus patient result values when us…
Filings

All 510(k) clearances (6)

Date K-number Device Code Class Specialty
2024-12-11 K243498 Alinity c Benzodiazepines Reagent Kit JXM
2024-10-30 K240670 DRI Ecstasy Plus Assay DKZ
2023-11-17 K231020 Alinity c Tricyclic Antidepressants Reagent Kit LFH Class II Clinical Toxicology
2023-09-27 K231007 CEDIA Heroin Metabolite (6-AM) Assay DJG Class II Clinical Toxicology
2022-12-21 K213875 DRI TM Tricyclics Serum Tox Assay LFH Class II Clinical Toxicology
2021-09-24 K211973 DRI Cocaine Metabolite Assay DIO Class II Clinical Toxicology